CD31 Polyclonal Antibody

The protein encoded by PECAM1 (platelet and endothelial cell adhesion molecule 1) is found on the surface of platelets, monocytes, neutrophils, and some types of T-cells, and makes up a large portion of endothelial cell intercellular junctions. The encoded protein is a member of the immunoglobulin superfamily and is likely involved in leukocyte migration, angiogenesis, and integrin activation.

The CD31 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CD31 protein expression in various biological samples. This antibody is produced using advanced techniques, ensuring exceptional quality and performance.

CD31, also known as platelet endothelial cell adhesion molecule-1 (PECAM-1), is a transmembrane glycoprotein primarily expressed on endothelial cells. It plays a crucial role in mediating cell adhesion, migration, and angiogenesis. The CD31 Polyclonal Antibody recognizes the extracellular domain of CD31, enabling precise identification and characterization of CD31-positive cells.

This antibody exhibits excellent sensitivity and specificity, making it an ideal choice for immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry applications. It has been extensively validated in various experimental settings, ensuring consistent and reproducible results.

The CD31 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for multiple experiments without compromising performance. The antibody is optimized for use in both research and clinical laboratories, facilitating a wide range of applications in the fields of oncology, cardiovascular research, and immunology.

With its exceptional quality and reliability, the CD31 Polyclonal Antibody is an indispensable tool for researchers and clinicians seeking to explore the intricate mechanisms underlying CD31-mediated processes. Trust in this antibody to deliver accurate and insightful results, advancing scientific understanding and contributing to the development of innovative therapeutic strategies.